Boothbay Fund Management, LLC Bicycle Therapeutics PLC Transaction History

Boothbay Fund Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$18.95 - $28.67 $16,031 - $24,254	-846 Reduced 1.97%	42,133 $1.08 Million
Q1 2023 May 15, 2023	BUY	$20.02 - $31.37 $860,439 - $1.35 Million	42,979 New	42,979 $914,000
Q2 2022 Aug 15, 2022	SELL	$12.95 - $46.99 $605,671 - $2.2 Million	-46,770 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$40.12 - $59.5 $667,837 - $990,437	-16,646 Reduced 26.25%	46,770 $2.05 Million
Q4 2021 Feb 14, 2022	BUY	$41.7 - $61.14 $354,867 - $520,301	8,510 Added 15.5%	63,416 $3.86 Million

Q3 2021 Nov 15, 2021	BUY	$27.95 - $44.24 $1.53 Million - $2.43 Million	54,906 New	54,906 $2.28 Million

30.6M

85.5K

11.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $600M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.